Sorafenib for advanced and refractory desmoid tumors

Authors

Brian A. Van Tine, Washington University School of Medicine in St. Louis

Journal

The New England Journal of Medicine

Publication Date

2018

Volume

379

Issue

25

Inclusive Pages

2417-2428

Document Type

Open Access Publication

DOI

10.1056/NEJMoa1805052

Rights and Permissions

Gounder, M. M., Mahoney, M. R., Van Tine, B. A., Ravi, V., Attia, S., Deshpande, H. A., . . . Schwartz, G. K. (2018). Sorafenib for Advanced and Refractory Desmoid Tumors. New England Journal of Medicine, 379(25), 2417-2428. doi:10.1056/NEJMoa1805052 Copyright © 2018 Massachusetts Medical Society. All rights reserved.

Recommended Citation

Van Tine, Brian A., "Sorafenib for advanced and refractory desmoid tumors." The New England Journal of Medicine. 379, 25. 2417-2428. (2018).
https://digitalcommons.wustl.edu/open_access_pubs/7690